Skip to content
National Family Caregivers Month: Recognizing 63 million Americans
November is National Family Caregivers Month, and to mark the occasion, Bio.News sat ...
Read More
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by ...
Read More
BIO Coffee Chat: Guiding patients through Part D open enrollment
Medicare’s 2026 Open Enrollment period for Part D plans began on Oct. 15 ...
Read More
BIO on the American Road: Indiana, a production powerhouse, is still expanding
At a time when the biopharma industry is seeking to increase U.S. manufacturing, ...
Read More
Ahead of BIO IP Conference, research highlights why biotech needs strong patents
Venture capital funding for life sciences startups plummeted after legal changes weakened the ...
Read More
PACE: Downstream effects of IRA on patients
Three years after the passage of the Inflation Reduction Act (IRA), patient advocates ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
Latest News
National Family Caregivers Month: Recognizing 63 million Americans
November is National Family Caregivers Month, and to mark the occasion, Bio.News sat down with the National Alliance for Caregiving (NAC) to discuss the crucial ...
BIO's View
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely access to essential medicines, a ...
Federal Policy
BIO Coffee Chat: Guiding patients through Part D open enrollment
Medicare’s 2026 Open Enrollment period for Part D plans began on Oct. 15 and runs through Dec. 7. “As patient advocates have seen year after ...
BIO Events
BIO on the American Road: Indiana, a production powerhouse, is still expanding
At a time when the biopharma industry is seeking to increase U.S. manufacturing, Indiana is in the vanguard—and still expanding. During a Nov. 11 BIO ...
BIO Events
Ahead of BIO IP Conference, research highlights why biotech needs strong patents
Venture capital funding for life sciences startups plummeted after legal changes weakened the patent system, according to new research that confirms the close relationship between ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
BIO PACE 2025: Patients need to ensure state policies enable access to medicine
With Medicaid cuts expected, vaccine hesitancy getting politicized, and the continued challenge of Prescription Drug Affordability Boards (PDABs), state legislatures ...
Read More
International
Bio's View
Oncologist warns PBM step therapy has ‘crossed a dangerous line’
Cancer patients are suffering serious health consequences because step therapy practices enforced by pharmacy benefit managers (PBMs) are preventing timely ...
Read More
